Recruiting soon

Superficial Cervical Plexus Block for Pain Relief in Maxillofacial Surgery

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to determine if a superficial cervical plexus block can delay the need for additional pain relief after maxillofacial surgery.

What is being tested

superficial cervical plexus nerve block

+ Bupivacaine

+ Saline (0.9% NaCl)

ProcedureDrug
Who is being recruted

From 18 to 65 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-Controlled
Interventional
Study Start: January 2026
See protocol details

Summary

Principal SponsorAssiut University
Study ContactRahma M. Atef, MBBCHMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2026

Actual date on which the first participant was enrolled.

This study is focused on evaluating a pain relief method called the superficial cervical plexus block (SCPB) for people undergoing maxillofacial surgeries, which involve operations on the jaw and face. The researchers are comparing this method to the more common approach of general anesthesia. SCPB is a technique where a local anesthetic is injected near certain neck nerves to help reduce pain. The study is particularly important because it may offer a way to reduce the need for systemic painkillers that affect the whole body after surgery, potentially leading to fewer side effects and complications. Participants in the study will receive either the SCPB or general anesthesia before their surgery. The SCPB involves an injection guided by ultrasound to ensure accurate placement of the anesthetic. Researchers will measure several outcomes, including how long pain relief lasts, how much extra pain medication is needed after the surgery, pain levels using a visual analog scale, and any changes in vital signs. They'll also monitor for any complications that might arise from the procedure. Some potential risks of SCPB include injection into a blood vessel, hematoma (a collection of blood outside of blood vessels), infection, or local anesthetic toxicity, although these risks are generally lower than with deeper nerve blocks.

Official TitleEvaluating the Analgesic Efficacy of Superficial Cervical Plexus Block for Maxillofacial Surgeries : A Comparative Randomized Control Study
Principal SponsorAssiut University
Study ContactRahma M. Atef, MBBCHMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

70 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate
Age 18-65 years

American Society of Anesthesiologists physical status classification (ASA) I - III

Patients scheduled for maxillofacial procedures involving submandibular area e.g. submandibular and submental abscesses, neck region e.g. cervical lymph node biopsies and ear lobe procedures.

BMI \< 30 kg/m2

5 exclusion criteria prevent from participating
Coagulopathy

Hypersensitivity to local anaesthetics used

Pre-existing neuropathy or neurological disease

Local infection ate the site of injection

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
patient will recived superficial Cervical plexus Block with 10 mL of 0.25% bupivacaine

Group II

Placebo
patients will recive IV saline only

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers